{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:29:22Z","timestamp":1790612962118,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Antibody-mediated rejection (AMR) is a leading cause of morbidity and mortality after kidney transplantation. Early diagnosis and treatment of subclinical AMR based on the donor-specific antibody (DSA) testing may result in better outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We tested this hypothesis in 220 kidney transplant recipients who underwent an indication or DSA-based surveillance protocol biopsies between March 1, 2013 and December 31, 2016. Patients were divided into 3 groups: clinical AMR (n = 118), subclinical AMR (n = 25), or no rejection on protocol biopsy (controls; n = 77).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Both clinical and subclinical AMR groups underwent similar treatment including plasmapheresis, pulse steroids, IVIG, and rituximab (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = ns). Mean follow-up after AMR was 29.5 \u00b1 16.8 months. There were 2 (3%), 2 (8%), and 54 (46%) death-censored graft failures in the control, subclinical, and clinical AMR groups, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Graft outcomes were similar in the subclinical rejection and control groups. In adjusted Cox regression analysis, only clinical rejection (hazards ratio [HR], 4.31; 95% confidence interval [CI], 1.01-18.94;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.05) and sum chronicity scores (HR, 1.16; 95% CI, 1.01-1.35;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03) were associated with increased risk of graft failure, while estimated glomerular filtration rate at time of biopsy (HR, 0.98; 95% CI, 0.96-0.99;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01) was associated with decreased risk of graft failure.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Our study suggests that early diagnosis and treatment of subclinical AMR using DSA monitoring may improve outcomes after kidney transplantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000002566","type":"journal-article","created":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T20:58:25Z","timestamp":1543697905000},"page":"1722-1729","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":94,"title":["Subclinical Antibody-mediated Rejection After Kidney Transplantation: Treatment Outcomes"],"prefix":"10.1097","volume":"103","author":[{"given":"Sandesh","family":"Parajuli","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Joachim","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayee","family":"Alagusundaramoorthy","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Blazel","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Aziz","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetika","family":"Garg","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Muth","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Mandelbrot","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjang","family":"Djamali","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."},{"name":"Division of Transplant Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260309","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"R2-20260309","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.humimm.2016.01.018","article-title":"Current outcomes of chronic active antibody mediated rejection\u2014a large single center retrospective review using the updated BANFF 2013 criteria.","volume":"77","author":"Redfield","year":"2016","journal-title":"Hum Immunol"},{"key":"R3-20260309","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"R4-20260309","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1681\/ASN.2012070664","article-title":"Donor-specific antibodies adversely affect kidney allograft outcomes.","volume":"23","author":"Mohan","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R5-20260309","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/TP.0b013e3182543950","article-title":"De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy.","volume":"94","author":"Willicombe","year":"2012","journal-title":"Transplantation"},{"key":"R6-20260309","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1600-6143.2006.01644.x","article-title":"Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival.","volume":"7","author":"Terasaki","year":"2007","journal-title":"Am J Transplant"},{"key":"R7-20260309","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2016030368","article-title":"Value of donor-specific anti-HLA antibody monitoring and characterization for risk stratification of kidney allograft loss.","volume":"28","author":"Viglietti","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R8-20260309","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody.","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant"},{"key":"R9-20260309","doi-asserted-by":"crossref","first-page":"e0178572","DOI":"10.1371\/journal.pone.0178572","article-title":"Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: results of an observational study.","volume":"12","author":"Matignon","year":"2017","journal-title":"PLOS One"},{"key":"R10-20260309","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches.","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant"},{"key":"R11-20260309","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1097\/TXD.0000000000000746","article-title":"Rituximab and monitoring strategies for late antibody-mediated rejection after kidney transplantation.","volume":"3","author":"Parajuli","year":"2017","journal-title":"Transplant Direct"},{"key":"R12-20260309","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.trre.2013.07.001","article-title":"Interpretation of HLA single antigen bead assays.","volume":"27","author":"Ellis","year":"2013","journal-title":"Transplant Rev (Orlando)"},{"key":"R13-20260309","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1111\/ajt.14466","article-title":"Utility of protocol kidney biopsies for de novo donor-specific antibodies.","volume":"17","author":"Parajuli","year":"2017","journal-title":"Am J Transplant"},{"key":"R14-20260309","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/ndt\/gfu371","article-title":"Better understanding of transplant glomerulopathy secondary to chronic antibody-mediated rejection.","volume":"30","author":"Remport","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"R15-20260309","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/j.1600-6143.2007.01895.x","article-title":"Transplant glomerulopathy: subclinical incidence and association with alloantibody.","volume":"7","author":"Gloor","year":"2007","journal-title":"Am J Transplant"},{"key":"R16-20260309","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1600-6143.2005.01050.x","article-title":"Predicting subsequent decline in kidney allograft function from early surveillance biopsies.","volume":"5","author":"Cosio","year":"2005","journal-title":"Am J Transplant"},{"key":"R17-20260309","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/j.1600-6143.2009.02813.x","article-title":"Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies.","volume":"9","author":"Loupy","year":"2009","journal-title":"Am J Transplant"},{"key":"R18-20260309","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.2014040399","article-title":"Subclinical rejection phenotypes at 1 year post-transplant and outcome of kidney allografts.","volume":"26","author":"Loupy","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R19-20260309","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1681\/ASN.V1071582","article-title":"Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages.","volume":"10","author":"Grimm","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R20-20260309","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1034\/j.1399-0012.1999.130601.x","article-title":"Does subclinical rejection contribute to chronic rejection in renal transplant patients?","volume":"13","author":"Rush","year":"1999","journal-title":"Clin Transplant"},{"key":"R21-20260309","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ki.1992.21","article-title":"Histopathological findings in well-functioning, long-term renal allografts.","volume":"41","author":"Isoniemi","year":"1992","journal-title":"Kidney Int"},{"key":"R22-20260309","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1046\/j.1523-1755.1999.00494.x","article-title":"Correlation of histology to clinical rejection reversal: a thymoglobulin multicenter trial report.","volume":"55","author":"Gaber","year":"1999","journal-title":"Kidney Int"},{"key":"R23-20260309","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1681\/ASN.V93482","article-title":"Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant.","volume":"9","author":"Nickerson","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R24-20260309","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.V9112129","article-title":"Beneficial effects of treatment of early subclinical rejection: a randomized study.","volume":"9","author":"Rush","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R25-20260309","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000225783.86950.c2","article-title":"Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants.","volume":"82","author":"Kee","year":"2006","journal-title":"Transplantation"},{"key":"R26-20260309","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/ajt.12982","article-title":"Quantifying renal allograft loss following early antibody-mediated rejection.","volume":"15","author":"Orandi","year":"2015","journal-title":"Am J Transplant"},{"key":"R27-20260309","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1600-6143.2006.01436.x","article-title":"The significance of subclinical rejection and the value of protocol biopsies.","volume":"6","author":"Nankivell","year":"2006","journal-title":"Am J Transplant"},{"key":"R28-20260309","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/ajt.12212","article-title":"De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.","volume":"13","author":"Kaneku","year":"2013","journal-title":"Am J Transplant"},{"key":"R29-20260309","article-title":"Outcomes of pancreas transplant recipients with de novo donor specific antibodies.","author":"Parajuli","journal-title":"Transplantation"},{"key":"R30-20260309","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival.","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"key":"R31-20260309","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1111\/ajt.13407","article-title":"De novo donor-specific HLA antibodies are associated with rapid loss of graft function following islet transplantation in type 1 diabetes.","volume":"15","author":"Brooks","year":"2015","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201908000-00032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:00:44Z","timestamp":1773072044000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201908000-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002566","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}